SPY380.36-1.97 -0.52%
DIA309.45-4.53 -1.44%
IXIC13,192.35+72.96 0.56%

Assertio Therapeutics Expects to Raise $14 Milion in Registered Direct Offering

· 02/04/2021 22:26

03:24 AM EST, 02/05/2021 (MT Newswires) -- Assertio Therapeutics (ASRT) is selling 22.6 million common shares to certain institutional investors at $0.62 per share, for gross proceeds of about $14.0 million.

The registered direct offering is expected to close on Feb. 9. Assertio plans to use proceeds for general corporate purposes, including general working capital.

Price: 0.7800, Change: +0.0850, Percent Change: +12.23